162 related articles for article (PubMed ID: 27307001)
21. Pitfalls in whole body MRI with diffusion weighted imaging performed on patients with lymphoma: What radiologists should know.
Albano D; La Grutta L; Grassedonio E; Patti C; Lagalla R; Midiri M; Galia M
Magn Reson Imaging; 2016 Sep; 34(7):922-31. PubMed ID: 27114337
[TBL] [Abstract][Full Text] [Related]
22. Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations.
Zugni F; Padhani AR; Koh DM; Summers PE; Bellomi M; Petralia G
Cancer Imaging; 2020 May; 20(1):34. PubMed ID: 32393345
[TBL] [Abstract][Full Text] [Related]
23. Whole-body MRI for the staging and follow-up of patients with metastasis.
Schmidt GP; Reiser MF; Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of whole-body MRI in the assessment of splenic involvement in lymphoma.
Littooij AS; Kwee TC; Barber I; Granata C; de Keizer B; Beek FJ; Hobbelink MG; Fijnheer R; Stoker J; Nievelstein RA
Acta Radiol; 2016 Feb; 57(2):142-51. PubMed ID: 25681490
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI.
Grueneisen J; Sawicki LM; Schaarschmidt BM; Suntharalingam S; von der Ropp S; Wetter A; Ruhlmann V; Quick HH; Forsting M; Umutlu L
PLoS One; 2016; 11(6):e0157880. PubMed ID: 27327617
[TBL] [Abstract][Full Text] [Related]
26. Whole-body magnetic resonance imaging: Incidental findings in paediatric and adult populations.
Preez HD; Lasker I; Rajakulasingam R; Saifuddin A
Eur J Radiol; 2020 Sep; 130():109156. PubMed ID: 32645680
[TBL] [Abstract][Full Text] [Related]
27. Investigating cancer patient acceptance of Whole Body MRI.
Oliveri S; Pricolo P; Pizzoli S; Faccio F; Lampis V; Summers P; Petralia G; Pravettoni G
Clin Imaging; 2018; 52():246-251. PubMed ID: 30170274
[TBL] [Abstract][Full Text] [Related]
28. Whole-body MRI vs. CT for staging lymphoma: patient experience.
Adams HJ; Kwee TC; Vermoolen MA; Ludwig I; Bierings MB; Nievelstein RA
Eur J Radiol; 2014 Jan; 83(1):163-6. PubMed ID: 24211036
[TBL] [Abstract][Full Text] [Related]
29. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
30. [Whole-body MRI in children with langerhans cell histiocytosis for the evaluation of the skeletal system].
Steinborn M; Wörtler K; Nathrath M; Schöniger M; Hahn H; Rummeny EJ
Rofo; 2008 Jul; 180(7):646-53. PubMed ID: 18561067
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the utility of whole-body MRI with and without contrast-enhanced Quick 3D and double RF fat suppression techniques, conventional whole-body MRI, PET/CT and conventional examination for assessment of recurrence in NSCLC patients.
Ohno Y; Nishio M; Koyama H; Yoshikawa T; Matsumoto S; Takenaka D; Seki S; Tsubakimoto M; Sugimura K
Eur J Radiol; 2013 Nov; 82(11):2018-27. PubMed ID: 24012452
[TBL] [Abstract][Full Text] [Related]
32. Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy.
Adams HJ; Kwee TC; Lokhorst HM; Westerweel PE; Fijnheer R; Kersten MJ; Verkooijen HM; Stoker J; Nievelstein RA
J Magn Reson Imaging; 2014 Jun; 39(6):1394-400. PubMed ID: 24310955
[TBL] [Abstract][Full Text] [Related]
33. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
[TBL] [Abstract][Full Text] [Related]
35. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.
Baur-Melnyk A; Buhmann S; Becker C; Schoenberg SO; Lang N; Bartl R; Reiser MF
AJR Am J Roentgenol; 2008 Apr; 190(4):1097-104. PubMed ID: 18356461
[TBL] [Abstract][Full Text] [Related]
36. Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT.
Manenti G; Cicciò C; Squillaci E; Strigari L; Calabria F; Danieli R; Schillaci O; Simonetti G
Eur J Radiol; 2012 Aug; 81(8):1917-25. PubMed ID: 21908120
[TBL] [Abstract][Full Text] [Related]
37. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods.
Goo HW; Choi SH; Ghim T; Moon HN; Seo JJ
Pediatr Radiol; 2005 Aug; 35(8):766-73. PubMed ID: 15864576
[TBL] [Abstract][Full Text] [Related]
38. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
39. Incidental findings at initial imaging workup of patients with prostate cancer: clinical significance and outcomes.
Elmi A; Tabatabaei S; Talab SS; Hedgire SS; Cao K; Harisinghani M
AJR Am J Roentgenol; 2012 Dec; 199(6):1305-11. PubMed ID: 23169722
[TBL] [Abstract][Full Text] [Related]
40. Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI.
Evans REC; Taylor SA; Kalasthry J; Sakai NS; Miles A;
Clin Radiol; 2020 Apr; 75(4):308-315. PubMed ID: 31836179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
